| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 500249 | KSB KSB Ltd | 03-Nov-2026 | KSB Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve unaudited financial results for quarter ended 30th September 2026 |
| 500414 | Timex Group Timex Group India Ltd | 03-Nov-2026 | Timex Group India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ending on September 30, 2026. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Timex Group India Limited - Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the shares of the Company shall remain closed from October 1, 2026 till November 5, 2026 (both days inclusive) on account of disclosure of Un-Audited Financial Results of the Company for the quarter and half year ending on September 30, 2026. |
| 500284 | Lords Chloro Lords Chloro Alkali Ltd | 03-Nov-2026 | Lords Chloro Alkali Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve Board Meeting intimation for approval of un-audited Financial Result for the second quarter and half year ended 30th September 2026 |
| 500257 | Lupin Lupin Ltd | 03-Nov-2026 | Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended September 30 2026. |
| 500490 | Bajaj Holdings Bajaj Holdings & Investment Ltd | 03-Nov-2026 | Bajaj Holdings & Investment Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026 |
| 500672 | Novartis India Novartis India Ltd | 03-Nov-2026 | Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30 2026. |
| 500680 | Pfizer Pfizer Ltd | 03-Nov-2026 | Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday November 3 2026 to consider approve and take on record the unaudited financial results for the quarter and half year ended September 30 2026. |
| 500660 | Glaxosmi. Pharma Glaxosmithkline Pharmaceuticals Ltd | 03-Nov-2026 | Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve As per attachment |
| 502157 | Mangalam Cement Mangalam Cement Ltd | 03-Nov-2026 | Mangalam Cement Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve to consider and approve the unaudited standalone Financial Results of the Company for the quarter and half year ended on 30th September 2026. |
| 503681 | Elcid Investment Elcid Investments Ltd | 03-Nov-2026 | EL CID Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30 2026. |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
